Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis
Fig 14
TCGA ROC curves for the prediction of the 3 years overall survival among the 4-lncRNA signature model, Gleason score and our lncRNA nomogram combined with Gleason score.